MOTS-c
Peptides

MOTS-c

Mitochondrial Open Reading Frame of the 12S rRNA-c

A mitochondrial-derived peptide that enhances metabolic function, improves insulin sensitivity, and promotes exercise-like benefits at the cellular level.

CGRADE · Low
18+ Studies35+ ReportsEmergingInjectableAvailable in UAE
62
Kamura ScorePromising
62/100
Promising
Emerging
Evidence
2-4 weeks
Time to Effect
AED 800-2,500/month
Est. Cost
Available
UAE Access
Last reviewed: March 2026
60
Research
75
Safety
55
Access
50
Value

How MOTS-c Works

MOTS-c is a 16-amino-acid mitochondrial-derived peptide encoded in the mitochondrial genome (12S rRNA gene). It functions as an exercise mimetic by activating AMPK (AMP-activated protein kinase), the master metabolic regulator, which enhances glucose uptake, improves insulin sensitivity, and promotes fatty acid oxidation. MOTS-c also translocates to the nucleus during metabolic stress to regulate nuclear gene expression, making it a unique mitochondrial-to-nuclear signaling peptide that helps maintain metabolic homeostasis and cellular resilience.

📊 Evidence by Outcome

Metabolic EnhancementB

Activates AMPK pathway, improves glucose metabolism. Animal data strong, human data emerging.

10 studies • Consistency: Moderate • Effect: Moderate

Exercise MimeticC

Mimics some benefits of exercise at the cellular level. Early-stage research.

5 studies • Consistency: Mixed • Effect: Unclear

📄

Key Research

Peer-Reviewed Evidence • 3 Citations

[1]

MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis

Reynolds JC et al.Nat Commun2021PMID: 34531413

Key Finding: MOTS-c treatment in aged mice improved physical performance comparable to exercise, regulating skeletal muscle gene expression.

View on PubMed
[2]

The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance

Lee C et al.Cell Metab2015PMID: 25738459

Key Finding: MOTS-c regulates metabolic homeostasis by targeting the methionine-folate cycle, preventing obesity and insulin resistance in mice.

View on PubMed
[3]

Mitochondrial-derived peptides in aging and age-related diseases

Kim SJ et al.J Biomed Sci2017PMID: 28245826

Key Finding: MOTS-c represents a new class of mitochondrial signaling peptides that regulate metabolism and may slow age-related metabolic decline.

View on PubMed

Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.

Side Effects & Safety

Common(3)
Mild injection site reactionTemporary increase in energy that may affect sleep if dosed lateMild muscle soreness (exercise-mimetic effect)
Rare(3)
HeadacheSlight nauseaTemporary changes in appetite
Serious(1)
Limited data — no serious adverse events reported in available studies. MOTS-c is a mitochondrial-derived peptide naturally produced by the body.

Interactions & Contraindications

Drug Interactions

  • May interact with metformin (overlapping AMPK activation mechanism; additive effect on glucose metabolism)
  • Caution with diabetes medications (may enhance insulin sensitivity and lower blood glucose)
  • Theoretical interaction with chemotherapy drugs (affects cellular metabolism)

Supplement Interactions

  • Synergistic with NAD+ precursors (NMN, NR) for mitochondrial function
  • Compatible with CoQ10 for cellular energy optimization
  • May complement berberine (shared AMPK activation pathway — monitor for additive glucose-lowering)

Food & Timing

  • Best taken on an empty stomach or with a light meal
  • Morning dosing preferred to align with metabolic activity
  • No known food interactions

Who Should Avoid

  • Active cancer (affects cellular metabolism and AMPK signaling)
  • Uncontrolled diabetes or hypoglycemia (potent metabolic effects)
  • Pregnancy and breastfeeding
  • Children under 18
  • Severe hepatic or renal impairment

📋 Protocol Snapshot

Standard
5mg 3x weekly
SubQ injection. 8-12 week cycles.

Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.

Cost Guide

AED 800-2,500/month

Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.

Frequently Asked Questions

MOTS-c is available through select peptide-focused wellness clinics in the UAE. It is a newer peptide and availability may be more limited. Source from clinics that provide third-party tested peptides.

Improved exercise performance and energy levels are commonly reported within 2-4 weeks. Metabolic improvements (fasting glucose, insulin sensitivity) may take 4-8 weeks to become measurable on blood work.

MOTS-c activates similar pathways to exercise (AMPK activation, improved glucose metabolism) and has been called an exercise mimetic in research. However, it does not replace exercise — it works best when combined with regular physical activity to amplify metabolic benefits.

Use caution as all three activate AMPK. Combining them may produce an additive glucose-lowering effect. If using together, start with lower doses, monitor blood glucose closely, and consult a practitioner experienced with peptide protocols.

Where to Get It (UAE)

Browse all wellness centers →

Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, safety, accessibility, and value — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.

My Stack

0 treatments

🧪

Your stack is empty. Browse treatments and click + to build your protocol.